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Iowa Department of Public Health 
Division of Behavioral Health/Bureau of Substance Abuse  
Opioid Update: November 2019 
 
The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Department News 
• Iowa News 
• Opioid News 




Reminder: Application Deadline is November 5, 2019, for Opioid Grants 
 
Through funding made available through the Substance Abuse and Mental Health Services 
Administration (SAMHSA) State Opioid Response (SOR) grant, IDPH is making available four 
grant funding opportunities to assist communities with addressing opioid issues.  
 
• Post Overdose Response: The awarded recipients will be required to create a Post 
Overdose Response team, designed to respond to opioid overdoses that occur within the 
community. This will include responding to requests for services from local emergency 
departments, law enforcement, EMS and other providers, to offer engagement and referral 
services to individuals and their families that have experienced an opioid overdose. A 
maximum of three funding awards will be made: up to $133,000 for each award is 
available. 
 
• Recovery Community Centers (RCC): The awarded recipients will be required to create 
a Recovery Community Center in their community. Funding from the SOR grant will 
provide annual support for the education, advocacy and recovery support services offered 
by the RCC, as a means of further strengthening Iowa’s multiple pathways of recovery 
approach. A maximum of four funding awards will be made: up to $180,000 for each 
award is available. 
 
• Screening, Brief Intervention and Referral to Treatment (SBIRT): The awarded 
recipients will be required to develop a collaborative partnership with an established 
primary care clinic/hospital and implement SBIRT services in order to increase facilitation 
of a “warm handoff” for behavioral health services. A maximum of four funding awards will 
be made: up to $100,000 for each award is available. 
 
• Corrections Liaison: The awarded recipients will be required to create a Coordinator 
position to work with incarcerated individuals receiving MAT services or being released 
and needing to access services in the community to which they return. A maximum of four 
funding awards will be made: up to $150,000 for each award is available. 
  
These funding opportunities will be awarded through a competitive procurement process to 
determine the most appropriate candidate. For more information, please visit the Iowa Grants 






Iowa Attorney General Supports Framework for $48 Billion Opioid Settlement 
 
Iowa Attorney General Tom Miller supports a $48 billion settlement framework with two drug 
makers and three distributors over their role in the opioid epidemic. “Many details need to be 
worked out, but this framework is an important step in addressing the crisis,” Miller said. “Any 
settlement must provide significant funds and treatment drugs to help people recover, as well as 
include requirements on the companies to prevent more addiction and death.” 
 
The drug manufacturers — Johnson & Johnson and Teva — and distributors — Cardinal 
Health, McKesson, and AmerisourceBergen — have agreed to the settlement in principle. The 
deal includes $22 billion in cash over 18 years and $26 billion in medication assisted treatment 
drugs and their distribution over 10 years. 
 




HHS Releases Guidance for Clinicians on the Appropriate Dosage Reduction or 
Discontinuation of Long-Term Opioid Analgesics  
 
After increasing every year for more than a decade, annual opioid prescriptions in the United 
States peaked at 255 million in 2012 and then decreased to 191 million in 2017. More judicious 
opioid analgesic prescribing can benefit individual patients as well as public health when opioid 
analgesic use is limited to situations where benefits of opioids are likely to outweigh risks. At the 
same time, opioid analgesic prescribing changes, such as dose escalation, dose reduction or 
discontinuation of long-term opioid analgesics, have potential to harm or put patients at risk if 
not made in a thoughtful, deliberative, collaborative and measured manner.  
 
To address this issue, the U.S. Department of Health and Human Services (HHS) developed 
the HHS Guide for Clinicians on the Appropriate Dosage Reduction or Discontinuation of Long-
Term Opioid Analgesics. The guide addresses a variety of issues and considerations to be 
made prior to initiating an opioid taper, in addition to an opioid tapering flowchart.    
 
For more information on the new guide, please click on the following link: HHS 
 
White House: Update on Opioid Crisis and Announcement of New Treatment 
Locator 
 
On Wednesday, October 30, 2019, the White House Office of Intergovernmental Affairs and 
Office of Public Liaison held a briefing call. The focus of the call was to provide an update on the 
opioid crisis and announce the launch of a new treatment locator tool.  
 
The call included updates from Assistant Secretary for Health at the U.S. Department of Health 
and Human Services (HHS) ADM Brett Giroir MD, Assistant Secretary for Mental Health and 
Substance Use Dr. Elinore McCance-Katz, and White House Advisor Kellyanne Conway. 
Conway talked about how the country is seeing a reduction in the number of overdose deaths, 
highlighting Iowa and a few other states for significant reductions. In addition to the update, the 
new treatment locator was introduced, which provides information on location, treatment 
options, payment and insurance information, and access to over 13,000 state-licensed facilities.  
 






Methamphetamine, Opioids and Poly-substance Use: December 3, 2019 
 
IDPH will be hosting a training titled, A Closer Look: Methamphetamine, Opioids and Poly-
Substance Use. The purpose of this event is to provide information about methamphetamine, 
opioid and poly-substance use, and explore their unique presentations. Speakers will discuss 
how these particular substances impact individuals compared to other types of substance use.  
 
Following the training, attendees will be able to: 
• Identify recent data trends that explain the complex presentation, and effective 
prevention and treatment of poly-substance use. 
• Identify local resources in the state of Iowa for accessing prevention and treatment 
services. 
• Identify the evidence and research that explains the impact on special populations 
affected by poly-substance use. 
 
The training will be held at the Ron Pearson Center in West Des Moines. For information on 
registering, please click on the following link: IDPH 
